Synthesis of antisense oligonucleotides conjugated to a multivalent carbohydrate cluster for cellular targeting.
Carrier-mediated delivery holds great promise for significantly improving the cellular uptake and therefore the therapeutic efficacy of antisense oligonucleotides in vivo. A multivalent carbohydrate recognition motif for the asialoglycoprotein receptor has been designed for tissue- and cell-specific delivery of antisense drugs to parenchymal liver cells. To combine low molecular weight with high receptor affinity, the synthetic ligand contains three galactosyl residues attached to a cholane scaffold via epsilon-aminocapramide linkers. Three-dimensional structural calculations indicate that this unique design provides proper spacing and orientation of the three galactosyl residues to accomplish high affinity binding to the receptor. Covalent conjugation of the bulky carbohydrate cluster to oligonucleotides has been achieved by solid-phase synthesis using low-loaded macroporous resins and optimized synthesis protocols.
Maier
Martin A
MA
Department of Medicinal Chemistry, Isis Pharmaceuticals, Inc., 2292 Faraday Avenue, Carlsbad, California 92008, USA.
Yannopoulos
Constantin G
CG
Mohamed
Nazim
N
Roland
Arlene
A
Fritz
Hans
H
Mohan
V
V
Just
George
G
Manoharan
Muthiah
M
D000818:Animals; D037263:Asialoglycoprotein Receptor; D002757:Cholanes / Q000737:chemistry; D003432:Cross-Linking Reagents / Q000737:chemistry; D004337:Drug Carriers / Q000138:chemical synthesis*; D015195:Drug Design; D005697:Galactosides / Q000737:chemistry*; D022781:Hepatocytes; D006801:Humans; D008024:Ligands; D015394:Molecular Structure; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage / Q000737:chemistry*
D037263:Asialoglycoprotein Receptor; D002757:Cholanes; D003432:Cross-Linking Reagents; D004337:Drug Carriers; D005697:Galactosides; D008024:Ligands; D016376:Oligonucleotides, Antisense